A clinical trial to study the effects of two drugs, R-TPR-023 and Avastinâ?¢ in patients with Metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2574628
下载链接
链接失效反馈官方服务：
资源简介：
Intervention1: R-TPR-023: Dose: 5 mg/kg,
Frequency: Every 2 weeks,
Route of Administration: Intravenously,
Duration: 3 years.
Control Intervention1: Avastinâ?¢: Dose: 5 mg/kg,
Frequency: Every 2 weeks,
Route of Administration: Intravenously, Duration: 3 years
Primary outcome(s): Outcome Name: Efficacy will be assessed as Objective Response Rate (Complete Response and Partial Response) by RECIST 1.1 criteria at 25 weeksTimepoint: 25 weeks
Study Design: Randomized, Parallel Group, Active Controlled Trial
Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Open Label
创建时间：
2013-06-15
